[May 15, 2014]

Research and Markets: Global Influenza A And B Infections Therapeutics Pipeline Review, H1 2014: 5 Companies & 6 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/8hn5q7/influenza_a_and_b) has announced the addition of the "Influenza A And B Infections - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Influenza A And B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza A And B Infections and special features on late-stage and discontinued projects.

Scope

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Influenza A And B Infections and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Influenza A And B Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Influenza A And B Infections pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products